Successful treatment of alopecia areata with topical calcipotriol.
Abstract
Alopecia areata (AA) is an inflammatory hair loss of unknown etiology. AA is chronic and relapsing, and no effective cure or preventive treatment has been established. Vitamin D was recently reported to be important in cutaneous immune modulation as well as calcium regulation and bone metabolism. It is well known that areata is common clinical finding in patients with vitamin D deficiency, vitamin D-resistant rickets, or vitamin D receptor (VDR) mutation. The biological actions of vitamin D3 derivatives include regulation of epidermal cell proliferation and differentiation and modulation of cytokine production. These effects might explain the efficacy of vitamin D3 derivatives for treating AA. In this study, we report a 7-year-old boy with reduced VDR expression in AA, recovery of whom was observed by topical application of calcipotriol, a strong vitamin D analog.
Used In Evidence Reviews
Similar Papers
Journal of the American Academy of Dermatology · 2019
Comorbidities in alopecia areata: A systematic review and meta-analysis.
American journal of clinical dermatology · 2018
Vitamin D and the Skin: An Update for Dermatologists.
Skin pharmacology and physiology · 2013
Serum ferritin and vitamin d in female hair loss: do they play a role?
American journal of clinical dermatology · 2017
The Role of Micronutrients in Alopecia Areata: A Review.
The Journal of clinical endocrinology and metabolism · 2019
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Experimental dermatology · 2017